Clinical trials
Postoperative Complications trials in Brazil with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Unknown status | 5 |
| Not yet recruiting | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Sao Paulo | 3 |
| University of Sao Paulo General Hospital | 3 |
| Hospital de Clinicas de Porto Alegre | 2 |
| Faculdade de Ciências Médicas da Santa Casa de São Paulo | 1 |
| Federal University of Mato Grosso | 1 |
| Federal University of Minas Gerais | 1 |
| Federal University of São Paulo | 1 |
| Hospital Erasto Gaertner | 1 |
| Igor Renato Louro Bruno de Abreu | 1 |
| Pontificia Universidade Catolica de Sao Paulo | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Postoperative Complications | 17 |
| Postoperative Nausea and Vomiting | 2 |
| Postoperative Pain | 2 |
| Acute Pain | 1 |
| Cardiovascular Diseases | 1 |
| Cognitive Dysfunction | 1 |
| Edema | 1 |
| Emergence Delirium | 1 |
| Head and Neck Neoplasms | 1 |
| Hernia, Abdominal | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.